Amplifon Valuation Multiples

Amplifon is valued at $3.8B as of October 2026, a 1.8x revenue multiple. In the last 12 months, Amplifon revenue was $2.7B and Amplifon EBITDA was $636M.

Amplifon Overview

About Amplifon

Amplifon is an Italian hearing care company founded in Milan in 1950 by Algernon Charles Holland, and it is the largest retailer of hearing aids in the world. It is listed on Euronext Milan, and Susan Carol Holland is its chairperson and Enrico Vita its chief executive. The group runs more than 10,000 points of sale in 26 countries, including direct and franchised shops under brands such as Amplifon and Miracle-Ear in the United States. It reported consolidated revenues of EUR 2.4 billion for 2025, up 1.7 percent, with adjusted EBITDA of EUR 540.4 million. It has grown through acquisitions of retail networks, including KIND in Poland in 2025, and is exiting weaker markets under its Fit4Growth programme, with the sale of its UK and Indian businesses in 2026. In March 2026 it signed an agreement to acquire the hearing business of GN Store Nord for about EUR 2.3 billion.


Founded

1950

HQ

Italy

Employees

15.1K

Financials (LTM)

Revenue: $2.7B
EBITDA: $636M

EV

$5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Amplifon Financials

Amplifon reported last 12-month revenue of $2.7B and EBITDA of $636M.

In the same LTM period, Amplifon generated $2.3B in gross profit, $636M in EBITDA, and $137M in net income.

Revenue (LTM)


Amplifon P&L

In the most recent fiscal year, Amplifon reported revenue of $2.7B and EBITDA of $558M.

Amplifon is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 21%, and net margin of 4%.

See analyst estimates for Amplifon
LTMLast FY202320242025202620272028
Revenue$2.7B$2.7B$2.6B$2.8B$2.7B
Gross Profit$2.3B$1.4B$1.5B$1.6B$1.4B
Gross Margin83%53%56%57%53%
EBITDA$636M$558M$604M$645M$558M
EBITDA Margin23%21%23%23%21%
EBIT Margin12%9%11%11%9%
Net Profit$137M$103M$179M$168M$103M
Net Margin5%4%7%6%4%
Net Debt-$1.3B---

Financial data powered by Morningstar, Inc.

Amplifon Stock Performance

Amplifon has current market cap of $3.8B, and enterprise value of $5B.

Market Cap Evolution


Amplifon's stock price is $14.41.

Amplifon share price increased by 4.8% in the last 30 days, and decreased by 15.9% in the last year.

Amplifon has an EPS (earnings per share) of $0.39.

See more trading valuation data for Amplifon
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$3.8B2.3%4.8%2.8%-15.9%$0.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Amplifon Valuation Multiples

Amplifon trades at 1.8x EV/Revenue multiple, and 7.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Amplifon

EV / Revenue (LTM)


Amplifon Financial Valuation Multiples

As of October 22, 2026, Amplifon has market cap of $3.8B and EV of $5B.

Amplifon has a P/E ratio of 28.0x.

LTMLast FY202320242025202620272028
EV/Revenue1.8x1.9x1.9x1.8x1.9x
EV/EBITDA7.9x9.0x8.3x7.8x9.0x
EV/EBIT15.2x21.9x17.3x17.1x21.9x
EV/Gross Profit2.2x3.5x3.4x3.2x3.5x
P/E28.0x37.3x21.3x22.8x37.3x
EV/FCF22.3x15.1x16.0x14.3x15.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Amplifon Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Amplifon Margins & Growth Rates

Amplifon grew revenue by 2% and EBITDA by 15% in the last fiscal year.

In the most recent fiscal year, Amplifon reported gross margin of 53%, EBITDA margin of 21%, and net margin of 4%.

See estimated margins and future growth rates for Amplifon

Amplifon Margins

Last FY202420252026202720282029
Gross Margin53%57%53%83%
EBITDA Margin21%23%21%23%
EBIT Margin9%11%9%12%
Net Margin4%6%4%5%
FCF Margin12%13%12%8%

Amplifon Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%7%(3%)2%
Gross Profit Growth58%7%(9%)58%
EBITDA Growth15%7%(13%)15%
EBIT Growth44%1%(22%)44%
Net Profit Growth41%(6%)(39%)41%
FCF Growth(33%)12%(6%)(33%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Amplifon Operational KPIs

Amplifon's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Amplifon's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Amplifon's Rule of X is 27% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Amplifon
LTMLast FY202320242025202620272028
Rule of 4045%25%---
Bessemer Rule of X79%27%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue0%0%--0%
Opex to Revenue-45%45%46%45%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Amplifon Competitors

Amplifon competitors include Mirion, Hamamatsu Photonics, MGI Tech, Jiangsu Yuyue Medical, iRhythm Holdings, Ottobock, Envista Holdings, Andon Health, Tecan Group and Pulse Biosciences.

Most Amplifon public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Mirion$925M$201M5.1x4.3x23.3x16.9x
Hamamatsu Photonics$1.3B$267M2.9x2.6x14.3x12.9x
MGI Tech$417M$19M8.5x7.6x181.9x69.3x
Jiangsu Yuyue Medical$1.2B$256M3.0x2.8x13.9x14.4x
iRhythm Holdings$747M($25M)5.3x4.5x(154.0x)35.5x
Ottobock$1.9B$424M2.6x2.5x11.8x9.7x
Envista Holdings$2.7B$365M1.5x1.5x11.5x10.3x
Andon Health$205M$74M17.5x-48.3x-

This data is available for Pro users. Sign up to see all Amplifon competitors and their valuation data.

Start Free Trial

Amplifon VC Funding History

Before going public, Amplifon raised $528M in total equity funding, across 1 round.


Amplifon Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
May-26Undisclosed stageTamburi Inv Partners$528M-Amplifon, the Milan-listed hearing care retailer, raised EUR 453 million on 21 and 22 May 2026 by placing 45.3 million new ordinary shares, about 20 percent of its capital before the increase, with qualified investors through an accelerated bookbuilding at EUR 10 per share. The price was a 5.66 percent discount to the closing price of EUR 10.6 on 21 May. Its existing shareholders Ampliter and Tamburi Investment Partners committed to subscribe new shares for EUR 130 million in total, of which EUR 100 million from Ampliter and EUR 30 million from TIP. The proceeds fund the cash component of the acquisition of the Hearing business of GN Store Nord, for which Amplifon also issues 56 million shares to GN Store Nord at closing. After the increase Ampliter retains control, with about 38.69 percent of the capital and 70.09 percent of the voting rights, and the share capital rises to 271,688,620 ordinary shares. Amplifon is the world leader in the distribution and fitting of hearing aids.

Acquisitions by Amplifon

Amplifon has acquired 6 companies to date.

Last acquisition by Amplifon was on March 15th 2026. Amplifon acquired GN Hearing for $2.7B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Amplifon

GN Hearing
Safe in Sound Hearing
SISH Tucson
KIND Aparaty Sluchowe
Description
GN Hearing is a Danish manufacturer of hearing aids.
Safe in Sound Hearing is a franchisee of Miracle-Ear that manages 23 retail locations across Arizona. The company delivers hearing aids, replacement parts, and accessory products tailored for individuals with hearing impairments. Operating under the Miracle-Ear trademark, Safe in Sound Hearing extends its hearing care services through these outlets in cities including Phoenix, Tucson, and Mesa.
SISH Tucson is an Arizona-based organization delivering hearing care services and products to clients worldwide.
KIND Aparaty Sluchowe is the Polish subsidiary of the German group KIND and was active in hearing healthcare retail in Poland. It operated a network of more than 120 points of sale, evenly divided between direct street stores and satellite part-time stores. The business had annual turnover of approximately EUR 10 million. Its network was fully complementary to Amplifon's presence in Poland, which then comprised about 115 direct shops. Amplifon acquired the entire share capital in March 2025 and planned to integrate the stores gradually under the Amplifon brand. The purchase doubled Amplifon's presence in Poland to more than 230 points of sale.
HQ CountryDenmarkUnited StatesUnited StatesPoland
HQ City
Copenhagen
Phoenix, AZ
Tucson, AZ
-
Deal Date15 Mar 202629 Apr 202529 Apr 202510 Mar 2025
Valuation$2.7Bundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Amplifon acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Amplifon

When was Amplifon founded?Amplifon was founded in 1950.
Where is Amplifon headquartered?Amplifon is headquartered in Italy.
How many employees does Amplifon have?As of today, Amplifon has over 15K employees.
Who is the CEO of Amplifon?Amplifon's CEO is Enrico Vita.
Is Amplifon publicly listed?Yes, Amplifon is a public company listed on Borsa Italiana.
What is the stock symbol of Amplifon?Amplifon trades under AMP ticker.
When did Amplifon go public?Amplifon went public in 2001.
Who are competitors of Amplifon?Amplifon main competitors include Mirion, Hamamatsu Photonics, MGI Tech, Jiangsu Yuyue Medical, iRhythm Holdings, Ottobock, Envista Holdings, Andon Health, Tecan Group, Pulse Biosciences.
What is the current market cap of Amplifon?Amplifon's current market cap is $3.8B.
What is the current revenue of Amplifon?Amplifon's last 12 months revenue is $2.7B.
What is the current revenue growth of Amplifon?Amplifon revenue growth (NTM/LTM) is 22%.
What is the current EV/Revenue multiple of Amplifon?Current revenue multiple of Amplifon is 1.8x.
What is the current EBITDA of Amplifon?Amplifon's last 12 months EBITDA is $636M.
What is Amplifon's EBITDA margin?Amplifon's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Amplifon?Current EBITDA multiple of Amplifon is 7.9x.
What is the current FCF of Amplifon?Amplifon's last 12 months FCF is $225M.
What is Amplifon's FCF margin?Amplifon's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Amplifon?Current FCF multiple of Amplifon is 22.3x.
How many companies Amplifon has acquired to date?As of October 2026, Amplifon has acquired 6 companies.
What was the largest acquisition by Amplifon?$2.7B acquisition of GN Hearing on 15th March 2026 was the largest M&A Amplifon has done to date.
What companies Amplifon acquired?Amplifon acquired GN Hearing, Gaes, KIND Aparaty Sluchowe, Magicson, Safe in Sound Hearing, and SISH Tucson.
In how many companies Amplifon has invested to date?Amplifon hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Amplifon

Lists including Amplifon

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial